Q
Qiagen N.V. (QGEN)
NYQ – Real Time Price. Currency in USD
33.70
+1.07 (3.28%)
At close: May 12, 2026, 4:00 PM EDT
33.30
-0.40 (-1.19%)
Pre-market: May 13, 2026, 7:31 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
33.70
+1.07 (3.28%)
At close: May 12, 2026, 4:00 PM EDT
33.30
-0.40 (-1.19%)
Pre-market: May 13, 2026, 7:31 AM EDT
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
| Name | Position |
|---|---|
| Dr. Dominic John | Vice President of Marketing & Product Management |
| Dr. Roland Sackers | CFO, MD & Member of Management Board |
| Dr. Thomas Schweins | Senior Vice President of Life Science Business Area |
| Dr. Thomas Theuringer | Senior Director & Head of External Communications |
| Mr. Antonio Santos | Senior VP & Head of Global Operations |
| Mr. Daniel Wendorff CEFA, CIIA | VP & Head of Investor Relations |
| Mr. Jean-Pascal Viola | Senior VP & Head of Corporate Strategy and Business Development |
| Mr. John Gilardi | VP & Head of Corporate Communications |
| Mr. Thierry L. Bernard | CEO, MD & Member of Management Board |
| Ms. Stephany Foster | Senior VP & Head of Human Resources |
| Date | Type | Document |
|---|---|---|
| 2026-05-08 | 6-K | a2026q1prform6-k.htm |
| 2026-05-01 | 6-K | a04272026q1preliminaryresu.htm |
| 2026-03-20 | 20-F | qgen-20251231.htm |
| 2026-02-06 | 6-K | a2025q4prform6-k.htm |
| 2025-12-22 | 6-K | a12182025ssbb6-k.htm |
| 2025-11-06 | 6-K | a2025q3prform6-k.htm |
| 2025-09-02 | 6-K | form6-kx2025convertibledebt.htm |
| 2025-08-21 | 6-K | a2025q2form6-k.htm |
| 2025-08-07 | 6-K | a2025q2prform6-k.htm |
| 2025-06-30 | 6-K | a06262025agmrelease.htm |